Podocytes, glucose and insulin
- 1 July 2010
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Nephrology and Hypertension
- Vol. 19 (4) , 379-384
Abstract
In the last decade the importance of the podocyte in maintaining the integrity of the glomerular filtration barrier and prevention of albuminuria has become obvious. The leading cause of renal failure in the developed world is diabetic nephropathy. This has a defined natural history of progressive albuminuria. The two fundamental cellular changes that occur in diabetes mellitus are a failure of insulin to signal to cells and an environment of hyperglycaemia. The emerging role of these factors on the biological function of the podocyte will be reviewed. Hyperglycaemia causes both deleterious and protective cellular pathways to be initiated in the podocyte, which communicate with other cell types in the glomerulus. Furthermore, the podocyte is an insulin-sensitive cell which can be directly modulated by factors that increase and decrease its sensitivity to insulin. Our understanding of the cellular processes that affect the podocyte in diabetes and insulin resistance has progressed greatly in recent years and hopefully will result in new treatment strategies against the leading cause of renal failure in the developed world.Keywords
This publication has 56 references indexed in Scilit:
- Urea-induced ROS generation causes insulin resistance in mice with chronic renal failureJournal of Clinical Investigation, 2010
- Mutations in the formin gene INF2 cause focal segmental glomerulosclerosisNature Genetics, 2009
- The anti-angiogenic isoforms of VEGF in health and diseaseBiochemical Society Transactions, 2009
- Role of altered insulin signaling pathways in the pathogenesis of podocyte malfunction and microalbuminuriaCurrent Opinion in Nephrology and Hypertension, 2009
- Nephrin Deficiency Activates NF-κB and Promotes Glomerular InjuryJournal of the American Society of Nephrology, 2009
- Rosiglitazone reduces renal and plasma markers of oxidative injury and reverses urinary metabolite abnormalities in the amelioration of diabetic nephropathyAmerican Journal of Physiology-Renal Physiology, 2008
- Therapeutic targets in focal and segmental glomerulosclerosisCurrent Opinion in Nephrology and Hypertension, 2008
- Advanced glycation endproducts induce podocyte apoptosis by activation of the FOXO4 transcription factorKidney International, 2007
- Selective impairment of gene expression and assembly of nephrin in human diabetic nephropathyKidney International, 2004
- Positionally Cloned Gene for a Novel Glomerular Protein—Nephrin—Is Mutated in Congenital Nephrotic SyndromeMolecular Cell, 1998